Astrazeneca (AZN) Depreciation & Amortization (CF) (2009 - 2026)
Astrazeneca's Depreciation & Amortization (CF) came in at $1.61 billion for Q3 2026, up 3.6% from $1.55 billion a year earlier but down 16.8% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Astrazeneca reported Depreciation & Amortization (CF) of $6.41 billion, down 2.3% year-over-year; for FY2025, it was $5.73 billion, down 14.3% from FY2024.
- Depreciation & Amortization (CF) carries a five-year compound annual growth rate of 12.7% (FY2020 to FY2025).
- Going back by year, Depreciation & Amortization (CF) was $6.69 billion in FY2024 (+24.2%), $5.39 billion in FY2023 (-1.7%), $5.48 billion in FY2022 (-16.1%) and $6.53 billion in FY2021 (+107.4%).
- The five-year range for quarterly Depreciation & Amortization (CF) is $1.26 billion (Q1 2024) to $2.34 billion (Q4 2024).
- Year-over-year, Depreciation & Amortization (CF) has increased for three consecutive quarters, with growth averaging 1.4% over the last seven quarters.
- The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q4 2021 (growth of 175.0%), and the weakest in Q4 2025 (a decline of 35.3%).
- Business Quant data shows AZN's Depreciation & Amortization (CF) at $1.93 billion (Q2 2026), $1.37 billion (Q1 2026) and $1.51 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,286.35 Bn | 1,259.96 Bn | 20.46 Bn | 545.00 Mn |
| 2 | Johnson & Johnson | 655.58 Bn | 575.44 Bn | 17.30 Bn | 2.12 Bn |
| 3 | AbbVie | 509.44 Bn | 477.50 Bn | 13.12 Bn | 192.00 Mn |
| 4 | Merck | 362.14 Bn | 325.14 Bn | 13.19 Bn | 726.00 Mn |
| 5 | Novartis Ag | 309.04 Bn | 282.62 Bn | - | - |
| 6 | Astrazeneca | 289.57 Bn | 263.55 Bn | 13.26 Bn | 1.61 Bn |
| 7 | Amgen | 248.97 Bn | 200.62 Bn | 7.58 Bn | 1.12 Bn |
| 8 | Gilead Sciences | 207.95 Bn | 182.98 Bn | 6.73 Bn | 132.00 Mn |
| 9 | Pfizer | 170.25 Bn | 117.91 Bn | 12.56 Bn | 1.58 Bn |
| 10 | Vertex Pharmaceuticals | 137.54 Bn | 109.53 Bn | 2.91 Bn | 69.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.61 Bn |
| Jun 30, 2026 | 1.93 Bn |
| Mar 31, 2026 | 1.37 Bn |
| Dec 31, 2025 | 1.51 Bn |
| Sep 30, 2025 | 1.55 Bn |
| Jun 30, 2025 | 1.39 Bn |
| Mar 31, 2025 | 1.28 Bn |
| Dec 31, 2024 | 2.34 Bn |
| Sep 30, 2024 | 1.82 Bn |
| Jun 30, 2024 | 1.28 Bn |
| Mar 31, 2024 | 1.26 Bn |
| Jun 30, 2023 | 1.28 Bn |
| Mar 31, 2023 | 1.50 Bn |
| Jun 30, 2022 | 1.36 Bn |
| Mar 31, 2022 | 1.31 Bn |
| Dec 31, 2021 | 2.19 Bn |
| Sep 30, 2021 | 2.79 Bn |
| Jun 30, 2021 | 753.00 Mn |
| Mar 31, 2021 | 797.00 Mn |
| Dec 31, 2020 | 797.00 Mn |
API Access
Astrazeneca Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();